Qiling Yiqi Tablets for HIV immune non-responders
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests if adding Qiling Yiqi Tablets (a Chinese herb formula) to your usual HIV medications can help people whose immune system hasn't fully recovered despite having undetectable HIV. It is for people with a specific TCM diagnosis called lung-spleen qi deficiency.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have HIV and have been on antiretroviral therapy (ART) for more than 4 years.
- Your HIV viral load has been undetectable (very low) for more than 3 years, but your CD4 count stays below 350.
- You have symptoms of lung-spleen qi deficiency syndrome, such as fatigue, poor appetite, weak voice, or loose stools.
- You don't have serious health problems like cancer, liver or kidney disease, or are pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a Chinese herbal medicine (Fuyang Jiedu Granules) to your regular HIV treatment can help raise your CD4 count. It's for people whose CD4 count stays low even after years of successful HIV treatment.
This trial tests if two drugs, baricitinib and sirolimus, can help control HIV after stopping standard antiretroviral therapy (ART). It aims to see if these immune treatments allow patients to maintain viral suppression without daily pills.
This trial tests a combination of two drugs that may 'wake up' hidden HIV in your body's cells, so that your immune system or other treatments can then eliminate it. The goal is to shrink the HIV reservoir that remains even when you're on antiretroviral therapy.
This trial tests a new medicine, GS-0415, for people with HIV who are already on a stable treatment plan. It aims to see how safe and effective the new medicine is.
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
This study tests targeted therapies to help HIV patients whose immune systems haven't fully recovered despite years of successful HIV medication. You may qualify if your CD4 count (a measure of immune health) stays low even though your viral load is undetectable.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.